GALT Competitors & Alternatives
Compare Galectin Therapeutics Inc with similar stocks in the same industry
Biotechnology
GALT
Main Stock$2.62
Tradestie Score
58
Market Cap
$267.77M
Analyst Upside
+319.8%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABEO
Abeona Therapeutics Inc. Common Stock
|
$5.67
|
$270.75M | 5.8 | 58 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$14.07
|
$269.08M | - | 48 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$7.73
|
$211.22M | - | 55 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.36
|
$202.58M | - | 58 | Compare |
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$14.60
|
$170.45M | - | 48 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$5.60
|
$158.43M | - | 59 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.49
|
$133.50M | - | 56 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$21.17
|
$110.20M | - | 54 | Compare |
|
LITS
Lite Strategy, Inc. Common Stock
|
$0.80
|
$91.28M | - | 49 | Compare |
More GALT Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry